Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
10/02/2012 | CA2795362A1 Compositions and methods for prediction of drug sensitivity, resistance, and disease progression |
10/02/2012 | CA2553833C Nucleic acid amplification with continuous flow emulsion |
10/02/2012 | CA2552949C Determination of hepatitis c virus genotype |
10/02/2012 | CA2515075C Sample processing |
10/02/2012 | CA2487779C P53 binding t cell receptor molecules and uses thereof |
10/02/2012 | CA2478111C A cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy |
10/02/2012 | CA2467215C Emulsion compositions |
10/02/2012 | CA2465895C Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding |
10/02/2012 | CA2452841C Method of sporulating eimeria oocytes |
10/02/2012 | CA2444649C Methods for nucleic acid manipulation |
10/02/2012 | CA2444259C Isolation of dna molecules using mercapto-aryl ligands |
10/02/2012 | CA2430135C Recombinant anti-cd30 antibodies and uses thereof |
10/02/2012 | CA2429813C Spatially directed ejection of cells from a carrier fluid |
10/02/2012 | CA2406830C Method for mutation detection in hiv using pol sequencing |
10/02/2012 | CA2396534C Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
10/02/2012 | CA2393482C Amplification based polymorphism detection |
10/02/2012 | CA2354672C Desaturases and methods of using them for synthesis of polyunsaturated fatty acids |
10/02/2012 | CA2332733C Signal peptides, nucleic acid molecules and methods for treatment of caries |
10/02/2012 | CA2311297C Erythrovirus and its applications |
10/02/2012 | CA2133306C Amplification of human mdm2 gene in human tumors |
09/30/2012 | CA2736087A1 Oligonucleotide probe for the detection of trypanosoma. cruzi (chagas d isease) in biological samples |
09/27/2012 | WO2012129558A1 Use of genetic testing of patient biopsy specimens to confirm patient identification |
09/27/2012 | WO2012129547A1 Functionalized 3-alkynyl pyrazolopyrimidine analogues as universal bases and methods of use |
09/27/2012 | WO2012129517A2 Evaluating protein expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer |
09/27/2012 | WO2012129488A2 Gene signatures associated with rejection or recurrence of cancer |
09/27/2012 | WO2012129444A2 Rapid tests for the detection of inhibitors of enzymes and human exposure to the same |
09/27/2012 | WO2012129436A1 Identification of linkage using multiplex digital pcr |
09/27/2012 | WO2012129412A1 Method for assembly of analyte filter arrays using biomolecules |
09/27/2012 | WO2012129378A1 Distinguishing benign and malignant indeterminate thyroid lesions |
09/27/2012 | WO2012129363A2 Single cell nucleic acid detection and analysis |
09/27/2012 | WO2012129360A2 Isolation and characterization of tumor cells using shear stress measurements |
09/27/2012 | WO2012129352A1 The kras variant and tumor biology |
09/27/2012 | WO2012129341A2 Disease detection in plants |
09/27/2012 | WO2012129312A2 Methods and systems for multiple control validation |
09/27/2012 | WO2012129263A2 Isothermal amplification of nucleic acid |
09/27/2012 | WO2012129242A2 Isolation of polymerase-nucleic acid complexes and loading onto substrates |
09/27/2012 | WO2012129237A2 Therapeutic agent for emphysema and copd |
09/27/2012 | WO2012129192A2 Mucin 5b as a pancreatic cyst fluid specific biomarker for accurate diagnosis of mucinous cysts and other markers useful for dection of pancreatic malignancy |
09/27/2012 | WO2012129187A1 Multiplexed digital assays with combinatorial use of signals |
09/27/2012 | WO2012129164A2 Biosensor |
09/27/2012 | WO2012129157A2 System for performing polymerase chain reaction nucleic acid amplification |
09/27/2012 | WO2012129126A1 Diagnosis and treatment of chronic lymphocytic leukemia (cll) |
09/27/2012 | WO2012129115A2 Materials and methods for profiling micrornas |
09/27/2012 | WO2012129100A1 Methods and compositions for predicting response to eribulin |
09/27/2012 | WO2012129092A1 Biomarkers for predicting the recurrence of colorectal cancer metastasis |
09/27/2012 | WO2012129048A2 Methods to predict sperm retrieval in males |
09/27/2012 | WO2012129008A1 Line-1 hypomethylation as a biomarker for early-onset colorectal cancer |
09/27/2012 | WO2012128904A1 Long interspersed nuclear elements (line-1) and alu hypomethylation as biomarkers for colorectal cancer metastasis |
09/27/2012 | WO2012128902A1 Changes in the expression of mir-200c/141 cluster of micrornas as biomarkers for epithelial-to-mesenchymal transition in human colorectal cancer metastasis |
09/27/2012 | WO2012128577A2 Method for performance analysis and screening of septicaemia protein therapeutic agents |
09/27/2012 | WO2012128377A1 Composition for treatment and diagnosis of pancreatic cancer |
09/27/2012 | WO2012128338A1 Method and kit for super-high-sensitivity measurement of protein and nucleic acid, and novel enzyme substrate |
09/27/2012 | WO2012127474A1 Method and kit for determining the time of seroconversion of a patient infected with a virus |
09/27/2012 | WO2012127413A1 Method for performing molecular reactions by using immiscible intermediate fluids |
09/27/2012 | WO2012127156A1 Improvement to bread-making with a high yeast content |
09/27/2012 | WO2012127062A1 Dominant negative hsp110 mutant and its use in prognosing and treating cancers |
09/27/2012 | WO2012127047A1 Constructs and method for regulating gene expression or for detecting and controlling a dna locus in eukaryotes |
09/27/2012 | WO2012127041A1 Method of screening antiretroviral compounds and vaccine |
09/27/2012 | WO2012126959A1 Method for high-throughput screening of drops by osmotic exchange and density variation |
09/27/2012 | WO2012126882A1 Identification of antiobiotic resistance |
09/27/2012 | WO2012126639A1 Modified hybridization probes |
09/27/2012 | WO2012126542A2 Biomarkers and methods for the prognosis of glioblastoma |
09/27/2012 | WO2012126398A1 Dna tag and use thereof |
09/27/2012 | WO2012126346A1 Method for rapidly determining dna content in cell nucleus |
09/27/2012 | WO2012126294A1 Biological chip hybridization system |
09/27/2012 | WO2012126162A1 Test kit for selection of esophageal cancer treatment protocols and/or prognostic evaluation |
09/27/2012 | WO2012126153A1 Method for multiplex detection of genomic dna polymorphism and probes dedicated thereto |
09/27/2012 | WO2012126091A1 Selective glycosidase inhibitors and uses thereof |
09/27/2012 | WO2012088105A3 Methods and compositions for predicting disease status in cancer |
09/27/2012 | WO2012081856A9 Method for preparing nucleic acid probe-coated porous solid support strip |
09/27/2012 | WO2012080359A3 Mhc genes and risk of graft versus host disease |
09/27/2012 | WO2012075313A3 Ph modulation methods and systems for detecting binding events |
09/27/2012 | WO2012074973A3 Electrophoresis gel system |
09/27/2012 | WO2012074550A3 Methods to assess treatment outcomes in reward deficiency syndrome (rds) behaviors utilizing expression profiling |
09/27/2012 | WO2012071461A3 Method of making and using fluorescent-tagged nanoparticles and microarrays |
09/27/2012 | WO2012070788A3 Method and kit for the quantification of nucleic acids |
09/27/2012 | WO2012069484A3 Method for qualitatively and quantitatively detecting specific nucleic acid sequences in real time |
09/27/2012 | WO2012068511A3 Method for amplification-free nucleic acid detection on optofluidic chips |
09/27/2012 | WO2012068392A3 Low cost, portable sensor for molecular assays |
09/27/2012 | WO2012068339A3 Methods of treating cancer |
09/27/2012 | WO2012068288A3 Diagnosing and monitoring cns malignancies using microrna |
09/27/2012 | WO2012046064A3 Prostate cancer stem cell differentiation |
09/27/2012 | WO2012033828A3 Methods for detecting human papillomavirus-associated cancers |
09/27/2012 | WO2012018982A3 Methods and kits for modulating tumor invasiveness and metastatic potential |
09/27/2012 | US20120246764 Optimized Endonucleases and Uses Thereof |
09/27/2012 | US20120246760 Triterpene oxidase derived from plant belonging to genus glycyrrhiza, gene encoding the same, and method of using the same |
09/27/2012 | US20120246757 Modulation of cellular protein function by artificial sumo ligases |
09/27/2012 | US20120246755 Brassica plants comprising mutant fad3 alleles |
09/27/2012 | US20120246748 Isolated novel acid and protein molecules from soy and methods of using those molecules to generate transgene plants with enhanced agronomic traits |
09/27/2012 | US20120246747 Rna-interference by single-stranded rna molecules |
09/27/2012 | US20120246745 Methods for Screening for Agents that Affect Development |
09/27/2012 | US20120245334 Methods of using fet labeled oligonucleotides that include a 3'-5' exonuclease resistant quencher domain and compositions for practicing the same |
09/27/2012 | US20120245235 Classification of cancers |
09/27/2012 | US20120245216 Compositions and methods for treatment of neuropathic pain |
09/27/2012 | US20120245166 Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such |
09/27/2012 | US20120245107 Methods of reducing the proliferation and viablility of microbial agents |
09/27/2012 | US20120245095 Biglycan and related therapeutics and methods of use |
09/27/2012 | US20120245092 Polypeptides having modulatory effects on cells |
09/27/2012 | US20120245048 Cellular response assay for biofluid biomarker discovery and detection |
09/27/2012 | US20120245047 Device and methods for molecular analysis |